BioMarin Pharmaceutical, Inc. (BMRN)
55.50
-1.74
(-3.04%)
USD |
NASDAQ |
Apr 02, 16:00
55.60
+0.10
(+0.18%)
After-Hours: 20:00
BioMarin Pharmaceutical Profit Margin (Quarterly) : -5.20% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.91% |
| Ionis Pharmaceuticals, Inc. | -112.8% |
| Mirum Pharmaceuticals, Inc. | -3.85% |
| Hims & Hers Health, Inc. | 3.33% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.89% |
| Return on Assets | 4.74% |
| Return on Invested Capital | 5.33% |
| Gross Profit Margin (Quarterly) | 68.65% |
| Operating Margin (Quarterly) | 11.16% |
| Return on Net Operating Assets | 9.70% |